Search research articles
Contact Us
Filters
Showing results (211-220 of 236) with videos related to
Page
of 24
Sort By:
Journal of Clinical Microbiology
|
August 13, 2024
Bridging the gap between molecular and genomic epidemiology in tuberculosis: inferring MIRU-VNTR patterns from genomic data
Sergio Buenestado-Serrano, Miguel Martínez-Lirola, Anzaan Dippenaar, et al.
American Journal of Respiratory and Critical Care Medicine
|
January 30, 2019
Spatial Network Mapping of Pulmonary Multidrug-Resistant Tuberculosis Cavities Using RNA Sequencing
Keertan Dheda, Laura Lenders, Shashikant Srivastava, et al.
American Journal of Respiratory and Critical Care Medicine
|
February 25, 2016
Genetic Determinants of Drug Resistance in Mycobacterium tuberculosis and Their Diagnostic Value
Maha R Farhat, Razvan Sultana, Oleg Iartchouk, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 19, 2023
Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective diagnostic accuracy study
Byron Wp Reeve, Gcobisa Ndlangalavu, Hridesh Mishra, et al.
The Lancet. Microbe
|
July 29, 2024
Bedaquiline: what might the future hold?
Emily S Shaw, Neil G Stoker, Jessica L Potter, et al.
Journal of Clinical Microbiology
|
December 16, 2011
Population structure of multi- and extensively drug-resistant Mycobacterium tuberculosis strains in South Africa
Violet N Chihota, Borna Müller, Charmaine K Mlambo, et al.
The Lancet. Global Health
|
April 7, 2024
Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective, cross-sectional, diagnostic accuracy study
Byron W P Reeve, Gcobisa Ndlangalavu, Hridesh Mishra, et al.
Ebiomedicine
|
May 11, 2021
Anaerobe-enriched gut microbiota predicts pro-inflammatory responses in pulmonary tuberculosis
Charissa C Naidoo, Georgina R Nyawo, Imran Sulaiman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 24, 2025
Insights into the Role of Rifampicin Exposure and Clinical Baseline Covariates on the Response to Pulmonary Tuberculosis Treatment
Marie Wijk, Paolo Denti, Kamunkhwala Gausi, et al.
Nature Microbiology
|
January 17, 2018
Mutations in ppe38 block PE_PGRS secretion and increase virulence of Mycobacterium tuberculosis
Louis S Ates, Anzaan Dippenaar, Roy Ummels, et al.
Page
of 24
Search research articles
Search
Showing results (211-220 of 236) with videos related to
Sort By:
Page
of 24
Journal of Clinical Microbiology
|
August 13, 2024
Bridging the gap between molecular and genomic epidemiology in tuberculosis: inferring MIRU-VNTR patterns from genomic data
Sergio Buenestado-Serrano, Miguel Martínez-Lirola, Anzaan Dippenaar, et al.
American Journal of Respiratory and Critical Care Medicine
|
January 30, 2019
Spatial Network Mapping of Pulmonary Multidrug-Resistant Tuberculosis Cavities Using RNA Sequencing
Keertan Dheda, Laura Lenders, Shashikant Srivastava, et al.
American Journal of Respiratory and Critical Care Medicine
|
February 25, 2016
Genetic Determinants of Drug Resistance in Mycobacterium tuberculosis and Their Diagnostic Value
Maha R Farhat, Razvan Sultana, Oleg Iartchouk, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 19, 2023
Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective diagnostic accuracy study
Byron Wp Reeve, Gcobisa Ndlangalavu, Hridesh Mishra, et al.
The Lancet. Microbe
|
July 29, 2024
Bedaquiline: what might the future hold?
Emily S Shaw, Neil G Stoker, Jessica L Potter, et al.
Journal of Clinical Microbiology
|
December 16, 2011
Population structure of multi- and extensively drug-resistant Mycobacterium tuberculosis strains in South Africa
Violet N Chihota, Borna Müller, Charmaine K Mlambo, et al.
The Lancet. Global Health
|
April 7, 2024
Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective, cross-sectional, diagnostic accuracy study
Byron W P Reeve, Gcobisa Ndlangalavu, Hridesh Mishra, et al.
Ebiomedicine
|
May 11, 2021
Anaerobe-enriched gut microbiota predicts pro-inflammatory responses in pulmonary tuberculosis
Charissa C Naidoo, Georgina R Nyawo, Imran Sulaiman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 24, 2025
Insights into the Role of Rifampicin Exposure and Clinical Baseline Covariates on the Response to Pulmonary Tuberculosis Treatment
Marie Wijk, Paolo Denti, Kamunkhwala Gausi, et al.
Nature Microbiology
|
January 17, 2018
Mutations in ppe38 block PE_PGRS secretion and increase virulence of Mycobacterium tuberculosis
Louis S Ates, Anzaan Dippenaar, Roy Ummels, et al.
Page
of 24